Pertinax Pharma appoint Nigel Brooksby as Chairman

Posted on

Pertinax are delighted to announce the appointment of Nigel Brooksby as the company’s first chairman.

Nigel has an unparalleled reputation in the pharmaceutical industry. He is Chairman of the UK Life Sciences Board and Board Member of the Cogent Skills Sector Council (SSC ) (the UK’s industry skills body for pharmaceutical, nuclear, petroleum , polymers and life sciences businesses).

Previously he held senior Global Appointments in Wellcome (now GSK) ,Pfizer and sanofi. He has worked internationally based in Europe , the USA, Latin America , the Middle East and Africa.

Nigel is a past President of the Association of the British Pharmaceutical industry (ABPI) and was honoured as a Lifetime Member in recognition of his services to the Life Sciences. He is a past Member of the CBI’s President’s Committee and is the current Chairman of the Pharmaceutical Directors Club ((PDC) , a Fellow of the Royal Society of Medicine , a Fellow of the Royal Society of Arts and a Friend of the Royal College of Physicians.

He is a Member of the UK Government’s Industrial Advisory Board which advises the Secretary of State for Business and his Ministers on applications for investment. He holds several Academic , Charity and Life Sciences Chairmanships and Board positions, which include the Clinical Trial Unit at Imperial College London and advising the Wellcome Trust.

Coverage of Nigel’s appointment can be found herehere and here.

November 2017